Vietnam Peripheral Vascular Devices Market Size and Growth 2032

Market Overview

The Vietnam Peripheral Vascular Devices market is expected to grow from USD 28.46 million in 2023 to USD 49.74 million by 2032, at a CAGR of 7.23%.

The growth of the Vietnam Peripheral Vascular Devices market is driven by the increasing prevalence of peripheral artery disease (PAD) and other vascular disorders, alongside the rising aging population. Advancements in medical technology, such as minimally invasive procedures, are also contributing to market expansion by offering improved treatment options with faster recovery times. Additionally, the growing adoption of diagnostic and therapeutic devices, including stents, catheters, and atherectomy devices, is fueling market demand. The government's focus on enhancing healthcare infrastructure and increasing awareness about vascular health further supports market growth. Moreover, the rise in healthcare investments, coupled with better reimbursement policies, is likely to accelerate the adoption of advanced vascular devices in Vietnam. These factors, combined with a growing demand for effective and cost-efficient healthcare solutions, are expected to drive the market's growth at a steady pace over the forecast period.

The Vietnam Peripheral Vascular Devices market is characterized by regional differences in healthcare infrastructure and patient access to advanced treatments. Southeast Vietnam, with its major urban centers like Ho Chi Minh City, leads in terms of healthcare development, creating a strong demand for peripheral vascular devices. Northern Vietnam, particularly around Hanoi, is experiencing steady growth due to expanding medical facilities and rising awareness of vascular diseases. Central and Southern Vietnam, while smaller in market presence, show potential for growth as healthcare access improves in these regions. Key players in the market include Terumo Corporation, Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, and Nipro Corporation, among others. These companies are instrumental in driving innovation and expanding the availability of advanced vascular treatment options. Their product portfolios range from angioplasty balloons and stents to guidewires and catheters, offering diverse solutions for peripheral artery disease and other vascular conditions.

cr_cta type="download_free_sample"]

Market Insights

• The Vietnam Peripheral Vascular Devices market was valued at USD 28.46 million in 2023 and is projected to reach USD 49.74 million by 2032, growing at a CAGR of 7.23%.
• Increasing prevalence of peripheral artery disease (PAD) and other vascular conditions is driving market growth.
• Technological advancements in vascular devices, such as minimally invasive procedures and drug-eluting stents, are gaining popularity.
• The shift towards outpatient procedures and cost-effective treatments is enhancing the adoption of vascular devices.
• Key players like Terumo Corporation, Medtronic, and Boston Scientific are leading the market, offering a wide range of vascular solutions.
• Limited access to healthcare in rural regions and high treatment costs are significant market restraints.
• Southeast Vietnam dominates the market, followed by Northern and Central Vietnam, while Southern Vietnam shows growing potential for market expansion.

Market Drivers

Rising Prevalence of Peripheral Artery Disease (PAD)

The increasing incidence of peripheral artery disease (PAD) in Vietnam is a significant driver of the peripheral vascular devices market. PAD, a condition that narrows the peripheral arteries, especially in the legs, is becoming more common due to factors such as aging populations, sedentary lifestyles, and rising levels of diabetes and hypertension. For instance, the prevalence of PAD in Vietnam has been linked to the growing number of diabetes cases, with over 5 million people affected by diabetes. This growing patient pool is creating a higher demand for advanced diagnostic and therapeutic vascular devices, which is boosting market growth. The need for effective treatments for PAD is expected to continue rising, further driving demand for these devices.

Healthcare Infrastructure Development

Vietnam's ongoing efforts to enhance healthcare infrastructure and access to modern medical technologies are contributing to the growth of the peripheral vascular devices market. The government's focus on expanding healthcare facilities, improving the quality of medical services, and increasing funding for advanced healthcare solutions is creating a more favorable environment for the adoption of advanced vascular devices. For instance, the Vietnamese government has been investing in the construction of new hospitals and clinics, which has significantly improved healthcare accessibility. With better infrastructure and improved access to healthcare, more patients will have access to treatments for vascular conditions, fueling market demand.

Advancements in Medical Technology

Technological advancements in peripheral vascular devices are playing a crucial role in market growth. Newer innovations, such as minimally invasive procedures using drug-eluting stents, advanced catheters, and atherectomy devices, have significantly improved treatment outcomes. These devices offer faster recovery times, reduced risk of complications, and improved patient outcomes compared to traditional surgical interventions. As these technologies become more widely adopted in Vietnam, they are expected to continue driving the market by offering enhanced solutions for peripheral vascular diseases.

Increasing Awareness and Healthcare Investments

Growing awareness about vascular diseases and their potential complications is also driving the market for peripheral vascular devices. As the public becomes more educated about the importance of early diagnosis and treatment, the demand for these devices is expected to rise. Furthermore, the increase in healthcare investments, both from the government and private sector, is making cutting-edge vascular treatments more accessible. This trend is expected to further propel the market by ensuring that advanced vascular devices are available to a broader segment of the population.

Market Trends

Integration of Artificial Intelligence (AI) in Diagnostics

The integration of artificial intelligence (AI) in diagnostics and treatment planning is another emerging trend in the Vietnam peripheral vascular devices market. AI-driven tools are helping healthcare professionals make more accurate diagnoses, leading to better patient outcomes. In particular, AI is being used to analyze medical images and vascular data, allowing for more precise identification of blockages and narrowing of arteries. For instance, AI-powered diagnostic tools have been implemented in several Vietnamese hospitals, enhancing the accuracy and speed of vascular disease diagnosis. This trend not only enhances the effectiveness of vascular treatments but also supports the growth of the market by increasing the use of advanced diagnostic tools and devices.

Shift Towards Minimally Invasive Procedures

One of the key trends in the Vietnam Peripheral Vascular Devices market is the growing preference for minimally invasive procedures. These procedures, which include the use of advanced catheters, stents, and atherectomy devices, are becoming the standard due to their advantages over traditional surgical methods. Patients benefit from shorter hospital stays, faster recovery times, and fewer complications, driving the demand for these innovative devices. As healthcare providers continue to adopt minimally invasive techniques, the market for peripheral vascular devices is expected to experience steady growth.

Increased Adoption of Drug-Eluting Stents

The adoption of drug-eluting stents (DES) is another significant trend in the Vietnam market. These devices are designed to release medication gradually to prevent the recurrence of artery blockages, providing long-term benefits for patients suffering from vascular diseases. With advancements in drug delivery mechanisms and improved stent designs, DES is becoming a preferred treatment option for peripheral artery disease (PAD). The growing focus on improving patient outcomes and reducing re-intervention rates is expected to increase the demand for drug-eluting stents in the coming years.

Focus on Cost-Effective Solutions

Cost-effectiveness is becoming a key focus in the Vietnam peripheral vascular devices market as patients and healthcare providers seek affordable treatment options. With rising healthcare costs and the increasing prevalence of vascular diseases, there is a growing demand for cost-efficient devices that provide high-quality treatment outcomes. Manufacturers are responding to this trend by developing products that balance affordability with advanced technology, making them accessible to a larger patient population. This trend is expected to drive the growth of the market, particularly in emerging regions of Vietnam.

Market Challenges Analysis

High Treatment Costs and Affordability Issues

A significant challenge facing the Vietnam peripheral vascular devices market is the high cost of treatment. Advanced peripheral vascular devices, such as drug-eluting stents, atherectomy devices, and other specialized equipment, are often expensive, making them inaccessible to a large portion of the population. For instance, the high cost of drug-eluting stents and atherectomy devices has been a barrier for many patients in Vietnam, particularly in rural areas. While these devices provide effective solutions for treating peripheral artery disease (PAD) and other vascular conditions, the cost can be prohibitive for many patients, especially those in rural or underserved regions. Additionally, the high costs of surgical procedures and post-treatment care contribute to the overall treatment burden. This affordability issue presents a barrier to market growth, as many patients may opt for less effective, lower-cost treatments or delay seeking care until conditions worsen.

Limited Access to Healthcare and Awareness

Another challenge in the Vietnam peripheral vascular devices market is limited access to healthcare, particularly in rural areas. While urban centers are seeing the growth of advanced healthcare facilities and vascular treatments, rural regions still struggle with inadequate healthcare infrastructure and limited availability of specialized medical equipment. This disparity restricts access to peripheral vascular devices for a significant portion of the population. Furthermore, while awareness of vascular diseases is growing, many individuals remain unaware of the early signs and symptoms of peripheral artery disease (PAD), leading to delayed diagnoses and treatment. The lack of education and awareness about vascular health, compounded by geographical challenges, continues to hinder the market's potential. Addressing these issues is essential to ensure broader access to advanced vascular treatments across the country.

Market Opportunities

Growing Demand for Advanced Treatment Options

Vietnam presents significant market opportunities for peripheral vascular devices due to the increasing prevalence of vascular diseases such as peripheral artery disease (PAD). As the population ages and lifestyle-related health issues like diabetes and hypertension rise, the demand for effective treatment options is growing. The adoption of minimally invasive procedures, including stenting and atherectomy, is gaining momentum, presenting opportunities for manufacturers to introduce advanced vascular devices that offer improved outcomes. The rising awareness among healthcare providers and patients about the benefits of these technologies further supports this demand, creating a favorable environment for new product introductions and expansions within the market.

Expansion of Healthcare Infrastructure and Investments

Vietnam's expanding healthcare infrastructure offers another key opportunity for the peripheral vascular devices market. With ongoing government investments in modern healthcare facilities and the growing focus on improving medical services, there is a greater push for the adoption of advanced medical technologies, including peripheral vascular devices. Additionally, the increasing presence of private healthcare providers and partnerships with global manufacturers presents opportunities for localized production and distribution of these devices. Expanding the availability of affordable treatment options in both urban and rural regions is critical for addressing the country's growing healthcare needs. This creates an opportunity for companies to capitalize on the expanding healthcare network and reach a broader patient base with innovative and cost-effective solutions.

Market Segmentation Analysis:

By Type

The Vietnam peripheral vascular devices market is segmented by type, which includes angioplasty balloons, angioplasty stents, catheters, guidewires, and others. Among these, angioplasty stents and angioplasty balloons hold the largest market share due to their widespread use in the treatment of peripheral artery disease (PAD) and other vascular conditions. Angioplasty balloons are used to dilate narrowed or blocked arteries, while stents are employed to keep arteries open after balloon angioplasty. Catheters and guidewires are essential tools in minimally invasive procedures, ensuring proper device placement and enhancing the overall effectiveness of the treatment. As the demand for minimally invasive surgeries continues to rise, these segments are expected to experience steady growth. Additionally, advancements in stent designs, such as drug-eluting stents, are fueling further demand. The "Others" category includes a variety of devices, such as atherectomy devices and thrombectomy tools, which are emerging as specialized treatments for vascular diseases.

By End-user

The market for peripheral vascular devices in Vietnam is also segmented based on end-user, including hospitals, ambulatory surgical centers (ASCs), and specialty clinics. Hospitals dominate the market due to their comprehensive healthcare offerings and ability to perform complex vascular surgeries. However, ambulatory surgical centers are experiencing significant growth, driven by the increasing preference for outpatient procedures and shorter recovery times associated with minimally invasive treatments. Specialty clinics, particularly those focusing on cardiovascular and vascular health, are also becoming key players in this market segment. As patient preferences shift toward outpatient treatments, the demand for peripheral vascular devices in these facilities is expected to rise. The evolving healthcare landscape in Vietnam, with an emphasis on improving accessibility and affordability, will continue to support the expansion of these end-user segments, offering substantial growth opportunities for peripheral vascular device manufacturers.

Segments:

Based on Type:

• Angioplasty Balloons
• Angioplasty Stents
• Catheters
• Guidewires
• Others

Based on End-user:

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics

Based on the Geography:

• Southeast Vietnam
• Northern Vietnam
• Central Vietnam
• Southern Vietnam

Regional Analysis

Southeast Vietnam

Southeast Vietnam holds the largest market share in the peripheral vascular devices market, accounting for approximately 45% of the total market. This region includes major urban centers such as Ho Chi Minh City, which has a well-established healthcare infrastructure and a high concentration of healthcare providers offering advanced vascular treatments. The rising prevalence of vascular diseases, particularly peripheral artery disease (PAD), is driving the demand for peripheral vascular devices in this region. The growing awareness of cardiovascular health, coupled with technological advancements in medical treatments, is further boosting the adoption of peripheral vascular devices in Southeast Vietnam. Additionally, this region benefits from higher healthcare investments, making it a prime market for innovative vascular solutions. As more patients seek effective and minimally invasive treatments, the demand for angioplasty stents, angioplasty balloons, and other peripheral vascular devices is expected to grow steadily in Southeast Vietnam.

Northern Vietnam

Northern Vietnam accounts for about 25% of the peripheral vascular devices market share. This region, with its growing cities like Hanoi, is experiencing an increase in healthcare infrastructure development, which is contributing to the rise in peripheral vascular procedures. The demand for vascular devices is growing as the prevalence of PAD and other vascular diseases rises among the aging population in the north. Although Northern Vietnam lags behind Southeast Vietnam in terms of healthcare availability, there is significant potential for market expansion due to government initiatives aimed at enhancing healthcare facilities and improving access to advanced medical technologies. The growing adoption of minimally invasive treatments and increasing public awareness about vascular health are key drivers of this market segment. Northern Vietnam is expected to see a steady increase in market share as healthcare access improves and patient education initiatives grow.

Central Vietnam

Central Vietnam represents a smaller portion of the market, contributing approximately 15% to the overall peripheral vascular devices market. Despite its relatively smaller market share, this region is showing substantial growth potential. Cities like Da Nang are seeing increased investments in healthcare infrastructure, which is improving the availability of advanced treatments and peripheral vascular devices. The demand for such devices is rising, as more patients in Central Vietnam seek treatments for vascular diseases. However, compared to Southeast and Northern Vietnam, Central Vietnam faces challenges such as limited access to specialized care and fewer healthcare facilities that offer cutting-edge treatments. Despite these challenges, Central Vietnam's market is expected to grow at a healthy pace due to increased healthcare investments and a growing awareness of vascular health in the region.

Southern Vietnam

Southern Vietnam, which accounts for around 15% of the market share, is gradually expanding its presence in the peripheral vascular devices market. This region, encompassing areas such as the Mekong Delta, has been historically underserved in terms of advanced healthcare. However, recent government and private sector investments are improving access to medical care and treatment options, including those for vascular diseases. The market in Southern Vietnam is driven by increasing healthcare accessibility and the rising burden of chronic diseases such as diabetes and hypertension, which contribute to the prevalence of PAD. While the region still lags behind Southeast and Northern Vietnam in terms of market share, there is significant growth potential, especially as more hospitals and clinics introduce advanced peripheral vascular treatments. The adoption of cost-effective and minimally invasive procedures in Southern Vietnam is expected to increase the demand for peripheral vascular devices over the coming years.

Key Player Analysis

• Terumo Corporation
• Medtronic plc
• Boston Scientific Corporation
• Abbott Laboratories
• Nipro Corporation
• Cook Medical
• Asahi Intecc Co., Ltd.
• B. Braun Melsungen AG
• MicroPort Scientific Corporation
• Cardinal Health

Competitive Analysis

The Vietnam Peripheral Vascular Devices market is highly competitive, with leading players such as Terumo Corporation, Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, Nipro Corporation, Cook Medical, Asahi Intecc Co., Ltd., B. Braun Melsungen AG, MicroPort Scientific Corporation, and Cardinal Health driving innovation and market growth. These players are constantly innovating to meet the growing demand for advanced vascular treatment solutions. For instance, Medtronic has been actively developing new stent technologies to improve patient outcomes. Companies are focusing on expanding their product portfolios to include minimally invasive devices like angioplasty balloons, stents, guidewires, and catheters, which are increasingly preferred for treating peripheral artery disease (PAD) due to their effectiveness and reduced recovery times. Additionally, the market is seeing heightened competition as manufacturers seek to differentiate their products with unique features, such as drug-eluting stents, which help prevent re-blockage of arteries. Strategic partnerships and collaborations are becoming crucial for companies to gain a competitive edge, especially in emerging markets like Vietnam. Furthermore, manufacturers are focusing on local production and distribution to reduce costs and improve accessibility in both urban and rural areas. As demand for peripheral vascular devices grows, companies are also investing in improving their sales channels, healthcare education, and customer support services to ensure better market penetration. The market remains dynamic, with firms vying for leadership through technological innovation, cost efficiency, and expanding access to vascular care.

Recent Developments

• In December 2024, Terumo Interventional Systems launched the R2P™ NaviCross® peripheral support catheter in the U.S. This catheter is designed for enhanced performance in radial-to-peripheral procedures, addressing the need for advanced tools in treating PAD and critical limb ischemia.
• In October 2024, BD was highlighted as a key player in the peripheral vascular devices market forecast report. While specific recent product launches were not detailed, BD's ongoing commitment to R&D and innovation positions it strongly within this competitive landscape.
• In June 2023, Cook Medical announced new size options for its Advance Serenity PTA Balloon Catheter, used for treating peripheral artery disease (PAD).
• In June 2023, Biotronik launched the Oscar multifunctional peripheral catheter, designed for dilation of stenotic segments in peripheral vessels. The device features user-adjustable components and aims to improve procedural efficiency in treating peripheral arterial disease.

Market Concentration & Characteristics

The Vietnam Peripheral Vascular Devices market exhibits moderate concentration, with a combination of well-established global players and emerging local companies. While global manufacturers dominate the market with advanced product offerings, local players are gradually increasing their market presence by offering cost-effective solutions tailored to the specific needs of the Vietnamese healthcare system. The market characteristics reflect a growing demand for high-quality, minimally invasive treatment options, such as angioplasty balloons, stents, and catheters, which provide faster recovery and fewer complications compared to traditional surgery. This shift towards less invasive procedures is driving competition among key players, prompting them to focus on innovation, product differentiation, and expanding their product portfolios to capture a larger share of the market. The market is also characterized by a strong push for technological advancements, particularly in drug-eluting stents and advanced guidewires, which are crucial for improving patient outcomes. Additionally, the market is witnessing a gradual expansion into rural areas, where healthcare access remains limited, presenting opportunities for growth. Regulatory frameworks and the affordability of treatments are key factors influencing market dynamics. As the healthcare infrastructure continues to improve, the market is expected to become more competitive, with new entrants introducing localized, cost-effective solutions to meet the increasing demand for vascular care in Vietnam.

Report Coverage

The research report offers an in-depth analysis based on Type, End-user and Geography. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook

1. The Vietnam Peripheral Vascular Devices market is expected to grow at a steady pace, driven by the increasing prevalence of vascular diseases.
2. Advancements in minimally invasive procedures, such as angioplasty and stenting, will continue to shape the market's future.
3. Technological innovations, particularly in drug-eluting stents and advanced guidewires, will enhance treatment outcomes and expand market opportunities.
4. Rising healthcare investments and improvements in infrastructure will make advanced vascular devices more accessible across urban and rural areas.
5. The growing preference for outpatient treatments will further boost demand for peripheral vascular devices in ambulatory surgical centers and specialty clinics.
6. An aging population, combined with increasing lifestyle-related diseases like diabetes and hypertension, will significantly contribute to market growth.
7. The market is likely to see an increase in competition, with both global players and local manufacturers focusing on cost-effective, high-quality solutions.
8. Enhanced healthcare education and awareness will lead to earlier diagnoses and higher demand for vascular treatments.
9. Regulatory support for medical device approvals and innovations will foster growth within the market.
10. The continued expansion of peripheral vascular device options and improved patient outcomes will drive long-term market sustainability.